Shanghai Labway Clinical Laboratory Co Ltd (301060) — Strategic Asset Allocation Index

Shanghai Labway Clinical Laboratory Co Ltd (301060) has a Strategic Asset Allocation Index of 10.5% as of June 2023. Strategic assets (PP&E of CN¥223.80 Million plus long-term investments of CN¥-) total CN¥223.80 Million, measured against net assets of CN¥2.13 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Shanghai Labway Clinical Laboratory Co L net asset quality index to measure how much of total assets are equity-financed.